Xeris Pharmaceuticals Inc (XERS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

180 NORTH LASALLE STREET CHICAGO, IL 60601

Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company produces peptides, proteins, antibodies, molecules, auto-injectors, multi-dose pens, and infusion pumps to treat endocrine and metabolic diseases. Xeris Pharmaceuticals serves patients in the State of Illinois.

Data as of 2021-04-03 12:18:40 -0400
Market Cap269.54 Million Shares Outstanding59.765 Million Avg 30-day Volume3.291 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-3.57 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.39832 52-week High/Low7.94 / 1.56 Next Earnings Date2021-05-06 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from XERS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 96 87 10.34% 26 (1.56%) 26 (1.62%) 0.0%
13F shares: 25.647 Million 25.264 Million 1.51% 12.23 Million 12.742 Million -4.02%
% Ownership 52.3661 51.5849 1.51% 24.9709 26.0158 -4.02%
New Positions: 22 24 -8.33% 6 7 -14.29%
Increased Positions 36 27 33.33% 8 3 166.67%
Closed Positions 13 24 -45.83% 6 16 -62.5%
Reduced Positions 24 21 14.29% 8 10 -20.0%
Total Calls 2.653 Million 2.299 Million 15.36% 360.5 Thousand 265.545 Thousand 35.76%
Total Puts 492.936 Thousand 70.072 Thousand 603.47% 291.5 Thousand 36.5 Thousand 698.63%
PUT/CALL Ratio 0.19 0.03 533.33% 0.81 0.14 478.57%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding XERS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XERS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DEUTSCH BARRY M. SEE REMARKS

  • Officer
208,090 2021-01-29 3

PRESTRELSKI STEVEN CHIEF SCIENTIFIC OFFICER

  • Officer
506,824 2021-01-29 5

JOHNSON KENNETH ERLAND SEE REMARKS

  • Officer
91,890 2021-01-29 3

SHANNON JOHN PATRICK JR SEE REMARKS

  • Officer
271,224 2021-01-29 5

EDICK PAUL R SEE REMARKS

  • Officer
  • Director
649,564 2021-01-29 3

HECHT BETH SEE REMARKS

  • Officer
210,814 2021-01-29 3

BORMANN-KENNEDY BARBARA-JEAN ANNE

  • Director
0 2020-06-04 1

SCHMID JOHN P.

  • Director
0 2020-06-04 1

SHERMAN JEFFREY W

  • Director
0 2020-06-04 1

HALKUFF DAWN

  • Director
0 2020-06-04 1

PERSKY MARLA

  • Director
0 2020-06-04 1

THIERER MARK

  • Director
0 2020-06-04 1

RIGBY JONATHAN

  • Director
0 2019-02-27 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
3,000,642 2019-02-19 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
2,355,136 2019-02-08 0

FLYNN JAMES E

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
4,972,728 2019-02-05 0

PALMETTO PARTNERS, LTD.

PALMETTO PARTNERS 2014, LP

PALMETTO PARTNERS 2015, LP

  • 10% Owner
2,110,061 2018-06-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
XERIS PHARMACEUTICALS INC XERS 2021-04-12 22:15:03 UTC -1.6107 1.6707 500000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 21:45:03 UTC -1.5921 1.6521 500000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 21:15:02 UTC -1.5921 1.6521 500000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 20:45:03 UTC -1.5885 1.6485 500000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 20:15:03 UTC -1.5885 1.6485 500000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 19:45:03 UTC -1.5885 1.6485 500000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 19:15:03 UTC -1.5885 1.6485 500000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 18:45:03 UTC -1.5637 1.6237 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 18:15:03 UTC -1.5637 1.6237 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 17:45:03 UTC -1.5637 1.6237 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 17:15:03 UTC -1.5637 1.6237 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 16:45:03 UTC -1.5649 1.6249 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 16:15:03 UTC -1.5649 1.6249 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 15:45:03 UTC -1.5649 1.6249 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 15:15:02 UTC -1.5649 1.6249 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 14:45:03 UTC -1.4933 1.5533 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 14:15:03 UTC -1.4933 1.5533 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 13:45:03 UTC -1.4933 1.5533 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 13:15:03 UTC -1.4933 1.5533 550000
XERIS PHARMACEUTICALS INC XERS 2021-04-12 12:45:03 UTC -1.4933 1.5533 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund XERS -1006.0 shares, $-9888.98 2019-09-30 N-PORT

Elevate your investments